E9-Rate of Macular Atrophy in HARBOR Study- Dr. SriniVas Sadda

Dr. SriniVas Sadda discusses development of macular atrophy in an analysis of HARBOR Study which investigated treatment of wet AMD using 0.5 mg and 2.0 mg of Ranibizumab dosing. Full reference of the discussed article: Sadda, S. R., Tuomi, L. L., Ding, B., Fung, A. E., & Hopkins, J. J. (2018). Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2017.12.026

Episode metadata supplied by the publisher feed · Published Mar 12, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

E9-Rate of Macular Atrophy in HARBOR Study- Dr. SriniVas Sadda

0:00 15:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Retina Channel Podcast?

This episode is 15 minutes long.

When was this The Retina Channel Podcast episode published?

This episode was published on March 12, 2018.

Can I download this The Retina Channel Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!